SIRIUS-LN: a Phase III Clinical Trial for a New Biologic in Lupus Nephritis
SIRIUS-LN: a Phase III Clinical Trial for a New Biologic in Lupus Nephritis Start and end date: Jul 2024- Jul 2029 Overview This study aims to look at how well ianalumab works in participants with renal manifestations in systemic lupus erythematosus, also called lupus nephritis (LN). To see if ianalumab can help to treat lupus nephritis […]
SIRIUS-SLE 1: a Phase III Clinical Trial for a New Biologic in Systemic Lupus Erythematosus
Current Research Completed Research Participate in Research SIRIUS-SLE 1: a Phase III Clinical Trial for a New Biologic in Systemic Lupus Erythematosus Start and end date: Jul 2024- Jul 2029 Overview This study aims to look at how well ianalumab works in participants with systemic lupus erythematosus. To see if ianalumab can help to treat […]
INTACT: RetINal Toxicity And HydroxyChloroquine Therapy Study
INTACT: RetINal Toxicity And HydroxyChloroquine Therapy Study Start and end date: January 1, 2021 – December 31, 2023 Overview The INTACT study aims to define the risk of retinal toxicity in patients with rheumatoid arthritis or systemic lupus erythematosus who have been using hydroxychloroquine (also known as Plaquenil) for five or more years. This risk […]